CN Patent

CN114591315A — 一种组织蛋白酶c小分子抑制剂

Assigned to Ruishi Biomedical Co ltd · Expires 2022-06-07 · 4y expired

What this patent protects

本公开涉及一种组织蛋白酶C小分子抑制剂。具体而言，本公开提供了一种式IV所示的酰胺腈类化合物，这些化合物具有一定的组织蛋白酶C的抑制作用。

USPTO Abstract

本公开涉及一种组织蛋白酶C小分子抑制剂。具体而言，本公开提供了一种式IV所示的酰胺腈类化合物，这些化合物具有一定的组织蛋白酶C的抑制作用。

Drugs covered by this patent

Patent Metadata

Patent number
CN114591315A
Jurisdiction
CN
Classification
—
Expires
2022-06-07
Drug substance claim
No
Drug product claim
No
Assignee
Ruishi Biomedical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.